Overall Management of Individualized Treatment for a Patient with Advanced NSCLC

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 19, Issue 2

Abstract

Objective: This article analyzes the overall management of a patient with advanced non-small cell lung cancer who has been managed for a total of 4 years and provides a reference for clinical case management. Methods: A Patient with advanced non-small cell lung cancer received multiline treatment including targeted therapy, immunotherapy, anti-vascular therapy, chemotherapy, and radiotherapy. The treatment of the patient during hospitalization was analyzed retrospectively. Results: Through targeted therapy, immunotherapy, chemotherapy and radiotherapy, the patient’s life span was extended to 4 years. Conclusion: For advanced lung cancer patients, a comprehensive, Individualized and precise diagnosis and treatment can significantly improve the prognosis of NSCLC.The patient was a 64 years old woman, who had no smoking history and no family history of tumor. The blood CEA 304ng/ ml was found in the January 2014 physical examination. PETCT showed right upper lung occupying and multiple lymph node metastases in the right supraclavicular, mediastinal and abdominal pelvis, with multiple small nodules in the upper and the lower lobe of the right lung. Right lung tumor biopsy found low differentiated adenocarcinoma. Molecular Profile was EGFR L858R mutation. According to the imaging and pathological data of this patient, the right lung adenocarcinoma was diagnosed as stage IV, with double lung and abdominal pelvic metastasis.

Authors and Affiliations

Shaozhong He, Qun Wang, Yongsheng Wang, Yao Sun

Keywords

Related Articles

Fast and Accurate Electrochemical Measurement of Total Antioxidant Capacity as an Alternative to Spectro photometrical Methods

Total Antioxidant Capacity or TAC is an indicator of the sample ability to scavenge free radicals despite its complex composition. It has been measured in biological fluids as an inverse biomarker of oxidative stress, wh...

Why It Is Important to Recognize Brugada Syndrome: A Case Report and Literature Review

Introduction: Brugada syndrome is a rare, but serious clinical entity that is the leading cause of sudden cardiac death in young healthy people. Symptoms associated with Brugada syndrome are caused by re- current ventric...

Evaluation of Various Factors Affecting Fluorescence Emission Behavior of Ochratoxin A: Effect of pH, Solvent and Salt Composition

In the present work, a design of customized portable fluorescence imaging system was developed (in-house) to quantify the change in fluorescence emission of fungal toxin ochratoxin A (OTA). OTA is naturally fluorescent,...

Studies on the Physicochemical Parameters of the Fixed Oils of Cinnamonum Zeylanicum

The present work was carried out to analyze the physicochemical parameters of fixed oils of Cinnamonum zeylanicum. The oil was extracted from freshly bark of Cinnamonum zeylanicum with petroleum ether using Soxhlet appar...

CD1b in Review: High TCR Specificity Limits Auto-Reactivity

The immune system is commonly divided into two broad sections: innate immunity and adaptive immunity. Innate immunity is described as non-specific and hereditary whereas adaptive immunity is characterized by high specifi...

Download PDF file
  • EP ID EP620642
  • DOI 10.26717/BJSTR.2019.19.003264
  • Views 120
  • Downloads 0

How To Cite

Shaozhong He, Qun Wang, Yongsheng Wang, Yao Sun (2019). Overall Management of Individualized Treatment for a Patient with Advanced NSCLC. Biomedical Journal of Scientific & Technical Research (BJSTR), 19(2), 1415-14163. https://europub.co.uk/articles/-A-620642